NOVA OCULUS PARTNERS, LLC
- Aug 6, 2020 · D/A · $22,500 sold of $15,000,000 · 2 investors · min. $25,000 · role: Executive Officer EDGAR ↗
- Jul 16, 2020 · D · $0 sold of $6,000,000 · 0 investors · min. $25,000 · role: Executive Officer EDGAR ↗
- Jul 30, 2019 · D · $0 sold of $5,500,000 · 0 investors · min. $5,000 · role: Executive Officer (Manager) EDGAR ↗
- Feb 4, 2019 · D/A · $265,000 sold of $5,500,000 · 7 investors · min. $5,000 · role: Executive Officer (Manager) EDGAR ↗
- Dec 4, 2018 · D/A · $250,000 sold of $5,500,000 · 5 investors · min. $5,000 · role: Executive Officer (Manager) EDGAR ↗
- Mar 16, 2018 · D/A · $250,000 sold of $5,500,000 · 5 investors · min. $5,000 · role: Promoter (Administrator) EDGAR ↗
- Feb 27, 2018 · D · $250,000 sold of $5,500,000 · 5 investors · min. $5,000 · role: Promoter (Administrator) EDGAR ↗
- Apr 12, 2017 · D · $119,419 sold of $7,500,000 · 3 investors · min. $5,000 · role: Promoter (Administrator) EDGAR ↗
Raised $1.79M from 47 investors (12% of the $15M target) as of the latest filing. Peter is listed as executive officer, promoter on 8 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(c) (171 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.